Receptor expression Cell surface expression of GIPR, GLP-1R and GCGR were determined by flow cytometry 24 h post-transfection in HEK293T cells
Strategies for phosphate control in patients with CKD
122 High-risk patients, such as those with multiple predisposing factors like T2DM, MASLD, rapid weight loss, and previous gallbladder disease, need more intensive treatment strategies, including periodic biochemical and imaging follow-up, and consideration of prophylactic treatment with ursodeoxycholic acid to prevent gallstone formation
Yes, Byetta is typically used as a long-term treatment
In this premier industry article, featuring Markens Senior Vice-President of Innovation and Strategic Operations, Dan Bell, shares valuable insights on how optimized logistics contribute to lower costs for drugs, like GLP-1s, providing a deeper understanding of the critical role Marken plays in helping drugs become more accessible to patients